Filtering by:
Cancer in ChildrenChildhood Leukemia Survivor Now a Happy, Active 4th-Grader
Childhood leukemia survivor Maddie Stanton describes herself as a “mainly regular” kid. “I feel good,” she says. Her mother, Denise, says, “We feel lucky every day to be able to have Maddie enjoying life, and being happy, and living.”
Facts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
Year in Review: Cancer Research Insights from 2017
Read highlights about American Cancer Society research from 2017.
Could Infections Teach Us How to Make Treatments for Pediatric ALL Even Better?
Alix Seif, MD, MPH, is studying a new type of immunotherapy that could teach the immune system long-term memory. The goal is for the immune system to kill any new leukemia cells for the rest of the child's life.
Adapting CAR T-Cell Therapy to Treat Neuroblastoma
With the success of the new drug, Kymriah, pediatric oncology researchers are trying to adapt CAR T-cell therapy to treat solid tumors, like neuroblastoma.
The Current and Future Promise of Immunotherapy for Childhood Cancers
Immunotherapy offers hope to children with cancer who don't respond to standard treatments. The new drug, Kymriah, is likely only the first to use CAR T-cell therapy, which helps immune cells identify cancer cells and kill them.
Caring for Children with Cancer
The types of cancers that develop in children are often different from the types that develop in adults. Even when kids have a cancer type that adults get too, it is often treated differently.
FDA Approves Mylotarg (Gemtuzumab Ozogamicin) for Acute Myeloid Leukemia
The US Food and Drug Administration (FDA) has approved Mylotarg (gemtuzumab ozogamicin) for adults and children with certain types of acute myeloid leukemia (AML).